Xie X - Search Results

1

miR-26a suppresses tumour proliferation and metastasis by targeting metadherin in triple negative breast cancer.

Liu P, Tang H, Chen B, He Z, Deng M, Wu M, Liu X, Yang L, Ye F, Xie X. Liu P, et al. Among authors: xie x. Cancer Lett. 2015 Feb 1;357(1):384-392. doi: 10.1016/j.canlet.2014.11.050. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434799

2

Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.

Ou-Yang F, Lan KL, Chen CT, Liu JC, Weng CL, Chou CK, Xie X, Hung JY, Wei Y, Hortobagyi GN, Hung MC. Ou-Yang F, et al. Among authors: xie x. Cancer Res. 2006 Jan 1;66(1):378-84. doi: 10.1158/0008-5472.CAN-05-1578. Cancer Res. 2006. PMID: 16397252

3

Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.

Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ. Xie ZM, et al. Cancer. 2011 Jul 15;117(14):3112-7. doi: 10.1002/cncr.25876. Epub 2011 Jan 26. Cancer. 2011. PMID: 21271559 Free article.

4

Targeted expression of Escherichia coli purine nucleoside phosphorylase and Fludara® for prostate cancer therapy.

Xie X, Guo J, Kong Y, Xie GX, Li L, Lv N, Xiao X, Tang J, Wang X, Liu P, Yang M, Xie Z, Wei W, Spencer DM, Xie X. Xie X, et al. Among authors: xie z, xie gx. J Gene Med. 2011 Dec;13(12):680-91. doi: 10.1002/jgm.1620. J Gene Med. 2011. PMID: 22009763

5

High serum HER2 extracellular domain levels: correlation with a worse disease-free survival and overall survival in primary operable breast cancer patients.

Kong Y, Dai S, Xie X, Xiao X, Lv N, Guo J, Li L, Jia W, Zhang Y, Liu W, Wei W, Xie X. Kong Y, et al. Among authors: xie x. J Cancer Res Clin Oncol. 2012 Feb;138(2):275-84. doi: 10.1007/s00432-011-1095-9. Epub 2011 Nov 25. J Cancer Res Clin Oncol. 2012. PMID: 22116318

6

Absence of evidence for epidermal growth factor receptor and human homolog of the Kirsten rat sarcoma-2 virus oncogene mutations in breast cancer.

Lv N, Lin S, Xie Z, Tang J, Ge Q, Wu M, Xie X, Xie X, Wei W. Lv N, et al. Among authors: xie x, xie z. Cancer Epidemiol. 2012 Aug;36(4):341-6. doi: 10.1016/j.canep.2012.01.004. Epub 2012 Mar 3. Cancer Epidemiol. 2012. PMID: 22386733

7

A case report of primary small cell carcinoma of the breast and review of the literature.

Ge QD, Lv N, Cao Y, Wang X, Tang J, Xie ZM, Xiao XS, Liu P, Xie XM, Wei WD. Ge QD, et al. Among authors: xie zm, xie xm. Chin J Cancer. 2012 Jul;31(7):354-8. doi: 10.5732/cjc.012.10012. Epub 2012 Apr 13. Chin J Cancer. 2012. PMID: 22516480 Free PMC article. Review.

8

MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1.

Li L, Yuan L, Luo J, Gao J, Guo J, Xie X. Li L, et al. Among authors: xie x. Clin Exp Med. 2013 May;13(2):109-17. doi: 10.1007/s10238-012-0186-5. Epub 2012 May 24. Clin Exp Med. 2013. PMID: 22623155

9

Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.

Wu M, Wei W, Xiao X, Guo J, Xie X, Li L, Kong Y, Lv N, Jia W, Zhang Y, Xie X. Wu M, et al. Among authors: xie x. Med Oncol. 2012 Dec;29(5):3240-9. doi: 10.1007/s12032-012-0260-6. Epub 2012 Jun 4. Med Oncol. 2012. PMID: 22661383

10

Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models.

Xie X, Li L, Xiao X, Guo J, Kong Y, Wu M, Liu W, Gao G, Hsu JL, Wei W, Hung MC, Xie X. Xie X, et al. Mol Cancer Ther. 2012 Sep;11(9):1915-24. doi: 10.1158/1535-7163.MCT-12-0191. Epub 2012 Jul 2. Mol Cancer Ther. 2012. PMID: 22752427

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,460 results

Search Page

Filters